|
|||||||
|
Although recent advancements in rheumatoid arthritis (RA) therapies have led to a increased number of available treatments, quite a few of those therapies have side effects that result in some users discontinuing treatment or seeking complementary and alternative medicines. A recently published study shows that the Chinese herb Tripterygium wilfordii Hook F (TwHF), also [...]
T-Cell (Orange) A new one time treatment is being tested by scientists in Great Britain which could potentially “switch off” rheumatoid arthritis. The researchers are theorizing that the drug will turn off the immune system response that is the cause of the debilitating disease. This may put the RA patient into remission for years, [...]
Macrophage In a properly functioning immune system, the immune cells are supposed to die after attacking an invading bacteria or virus. This process of cell death is called apoptosis. “In apoptosis, a cell quietly dies off and gets removed from the system. That’s the way our body has of renewing itself all the time. [...] Scientists have found that in countries where parasitic infections are common the incidence of autoimmune diseases is relatively small. One hypothesis is that a chemical secreted by parasitic worms may have anti-inflammatory properties. If true, it may lead to a potential treatment for rheumatoid arthritis. [...] According to a drug trial that was presented at the American College of Rheumatology in San Francisco indicates that methotrexate, when used in combination with tocilizumab, resulted in remission in 47% of the patients. This compares to only 8% for patients on methotrexate alone. [...] Rheumatoid arthritis (RA) is an auto-immune, inflammatory disease. People with rheumatoid arthritis (RA) have higher levels of inflammatory proteins, called cytokines, and other cytokine related factors in their blood. According to a recent study, those markers are present as many as three years before any RA symptoms emerge. Previous studies have shown that other [...] A novel new drug, based on the commonly used prednisone, has been recommended for European regulatory approval for treatment of morning stiffness resulting from rheumatoid arthritis. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
